New Jersey 2026-2027 Regular Session

New Jersey Assembly Bill A3512

Introduced
1/13/26  

Caption

Establishes "Equitable Drug Pricing and Patient Access Act."

Impact

The bill introduces significant reforms to Medicaid managed care contracts by requiring that they include pharmacy choice as a mandatory benefit for enrollees. This ensures that all qualified pharmacies can dispense medications to Medicaid beneficiaries, contributing to a more competitive healthcare environment. By improving access to various pharmacies, the legislation aims to enhance patient choices and rectify existing limitations that have hindered access to medications for enrollees in the program.

Summary

Assembly Bill A3512, titled the 'Equitable Drug Pricing and Patient Access Act,' aims to enhance the drug pricing structure within New Jersey's Medicaid program. The bill mandates that pharmacies providing services to Medicaid beneficiaries receive a reimbursement rate that is no less than the national average drug acquisition cost plus a professional dispensing fee. This change is intended to ensure that pharmacies are fairly compensated, thereby improving their ability to serve Medicaid enrollees effectively and without financial detriment.

Contention

Notable points of contention surrounding A3512 arise from the complexities and financial implications of such reforms. Critics may argue that instituting higher reimbursement rates could lead to an increased burden on state finances or that such regulations could unintentionally limit the ability of Medicaid managed care organizations to negotiate better deals with pharmacies. Furthermore, some stakeholders in the healthcare industry may express concerns over the impacts on pharmacy benefit managers or how these changes could alter the existing dynamics of prescription drug pricing.

Additional_notes

The act also calls for the State Auditor to evaluate pharmacy pricing practices, indicating an increased emphasis on transparency and accountability in Medicaid expenditures related to prescription drugs. As state spending on Medicaid and prescription drugs has escalated markedly in recent years, this initiative seeks to provide better oversight and management of the resources dedicated to these services to prevent waste and improve efficiency.

Companion Bills

NJ S3538

Carry Over Establishes "Equitable Drug Pricing and Patient Access Act."

NJ A5531

Carry Over Establishes "Equitable Drug Pricing and Patient Access Act."

NJ S2621

Same As Establishes "Equitable Drug Pricing and Patient Access Act."

Similar Bills

NJ S2621

Establishes "Equitable Drug Pricing and Patient Access Act."

HI SB2208

Relating To Pharmacy Benefit Managers.

NV SB389

Revises provisions relating to the administration of pharmacy benefits under Medicaid and certain other health plans. (BDR 38-240)

FL H0657

Medicaid Pharmacy Discounted Drug Prices

NV SB149

Revises provisions governing the administration of pharmacy benefits under Medicaid. (BDR 38-224)

FL H0697

Drug Prices and Coverage

SC S0342

Pharmacy services

AR HB1354

To Regulate Pharmacy Benefits Managers; To Amend The Law Concerning The State And Public School Life And Health Insurance Program; And To Amend The Law Concerning Certain Health Benefit Plans.